<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, April 16, 2019 (HealthDay News) — Trigeminal nerve stimulation (TNS) showed efficacy when compared with a similar sham procedure for the treatment of attention-deficit\/hyperactivity disorder (ADHD) in children, according to a double-blind, controlled pilot study published in the April issue of the Journal of the American Academy of Child & Adolescent Psychiatry<\/i>.<\/p>\n
James J. McGough, M.D., from the University of California in Los Angeles, and colleagues randomly assigned 62 children (aged 8 to 12 years with full-scale IQ of \u226585) diagnosed with ADHD to four weeks of nightly treatment with either active or sham TNS followed by one week without intervention. Study assessments included weekly clinician-administered ADHD Rating Scales (ADHD-RS) and Clinical Global Impression (CGI) scales plus quantitative electroencephalography at baseline and week 4.<\/p>\n
The researchers found that ADHD-RS total scores showed significant group-by-time interactions. Active treatment was also associated with CGI-Improvement (number needed to treat was three). There was increased spectral power in the right frontal and frontal midline frequency bands with active TNS, as seen on resting-state quantitative electroencephalography. No clinically meaningful adverse events were reported in either group.<\/p>\n
“Additional research should examine treatment response durability and potential impact on brain development with sustained use,” the authors write.<\/p>\n
Several authors disclosed financial ties to NeuroSigma, which provided the study devices.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n